HIGHLIGHTS
- who: Zongtai Zheng and collaborators from the Department of Urology, Guangdong Second Provincial General Hospital, Guangzhou, China Urologic Institute, Tongji University School of Medicine, Shanghai, China have published the paper: CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer, in the Journal: Cancers 2022, 4866 of 10/04/2022
- what: The authors aimed to investigate the clinical value of CD8A in prognosis and tumor microenvironment (TME) and preoperatively predict the expression of CD8A using radiogenomics in_(BCa). The aim of this study was to assess the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.